HTL Hamilton Thorne Inc

BEVERLY, MA and TORONTO, ON--(Marketwired - Mar 21, 2014) - Hamilton Thorne Ltd. (TSX-VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has granted a total of 1,450,000 stock options to purchase common shares pursuant to the Company's incentive stock option plan. The options are exercisable at Cdn$0.05 per share, and expire ten years from the date of grant. A total of 1,100,000 of these options were granted to the Company's Directors, CEO, CTO and CFO. Grants to non-employee Directors vest over three years; grants to employees vest over four years.

About Hamilton Thorne Ltd. (www.hamiltonthorne.com)

Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced image analysis systems for the fertility, stem cell and development biology research markets. It provides novel solutions for Life Science that reduce cost, increase productivity, improve results and enable research breakthroughs in regenerative medicine, stem cell research and fertility markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF procedures. Its image analysis systems improve outcomes in human IVF clinics and animal breeding facilities and provide high-end toxicology analyses.

Hamilton Thorne's growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge.

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at www.sedar.com.

For more information, please contact: David Wolf President & CEO Hamilton Thorne Ltd. 978-921-2050 Email Contact Michael Bruns CFO Hamilton Thorne Ltd. 978-921-2050 Email Contact

Hamilton Thorne (TSXV:HTL)
Graphique Historique de l'Action
De Oct 2024 à Déc 2024

Hamilton Thorne (TSXV:HTL)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024